medication compliance
Medications
Instructed in new medication Advil and in S/E such as headache, dizziness, nervousness, aseptic meningitis, peripheral edema, fluid retention, tinnitus, epigastric distress, nausea, occult blood loss, peptic ulceration, diarrhea, constipation, dyspepsia, flatulence, heartburn, decreased appetite, acute renal failure, azotemia, cystitis, hematuria, prolonged bleeding time, anemia, neutropenia, pancytopenia, thrombocytopenia, aplastic anemia, leukopenia, agranulocytosis, hypoglycemia, hyperkalemia, hypouricemia, bronchospasm, pruritus, rash, urticaria and Stevens-Johnson syndrome.
Instructed in new medication Toprol and in S/E such as fatigue, dizziness, depression, bradycardia, hypotension, heart failure, AV block, nausea, diarrhea, dyspnea and rash.
Instructed in new medication Pulmicort to manage asthma. In addition, warned of possible S/E such as headache, pain, insomnia, asthenia, rhinitis, voice alteration, sinusitis, pharyngitis, dry mouth, nausea, vomiting, abdominal pain, taste perversion, cought, etc.
Instructed in new medication Avapro to manage hypertension. In addition, warned of possible S/E such as fatigue, anxiety, dizziness, headache, chest pain, edema, tachycardia, pharyngitis, rhinitis, sinus abnormality, diarrhea, dyspepsia, abdominal pain, nausea, vomiting, urinary tract infection, musculoskeletal trauma, or pain, upper respiratory tract infection, rash.
Instructed in new medication Bextra to manage osteoarthritis. In addition. warned of possible S/E such as dizziness, headache, cerebrovascular disorder, peripheral edema, hypertension, angina pectoris, arrhythmia, heart failure, aneurysm, sinusitis, abdominal fullness, abdominal pain, diarrhea, dyspepsia, flatulence, nausea, renal impairment, thrombocytopenia, leukopenia, anemia, hepatitis, hyperglycemia, hypercholesterolemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypocalcemia, hypokalemia, increased or decreased weight, back pain, myalgia, upper respiratory tract infection, bronchospasm, rash, flu-like syndrome, accidental injury.
Instructed in new medication Calcium and in S/E such as headache, weakness, dizziness, paresthesia, chest pressure, facial flushing, edema of feet, eye pain, nasal congestion, transient nausea, unusual taste, diarrhea, anorexia, vomiting, epigastric discomfort, abdominal pain, increased urinary frequency, nocturia, shortness of breath, rash, pruritus of ear lobes, inflammation at injection site, hypersensitivity reactions (anaphylaxis), chills and tender palms and soles.
Instructed in new medication Sulfaprim and in S/E such as headache, mental depression, aseptic meningitis, tinnitus, apathy, seizures, hallucinations, ataxia, nervousness, fatigue, vertigo, insomnia, thrombophlebitis, nausea, vomiting, diarrhea, abdominal pain, anorexia, stomatitis, pancreatitis, pseudomembranous colitis, toxic nephrosis with oliguria and anuria, crystalluria, hematuria, interstitial nephritis, agranulocytosis, aplastic anemia, megaloblastic anemia, thrombocytopenia, leukopenia, hemolytic anemia, jaundice, hepatic necrosis, arthralgia, myalgia, muscle weakness, pulmonary infiltrates, erythema multiforme, Stevens-Johnson syndrome, generalized skin eruption, toxic epidermal necrolysis, exfoliative dermatitis, photosensitivity, urticaria, pruritus, hypersensitivity reactions, serum sickness, drug fever and anaphylaxis.
Instructed in new medication Allopuriniol and in S/E such as drowsiness, fever, headache, paresthesia, peripheral neuropathy, neuritis, hypersensitivity vasculitis, necrotizing angiitis, epistaxis, nausea, vomiting, diarrhea, abdominal pain, gastritis, taste loss (or perversion, dyspepsia), renal failure, uremia, agranulocytosis, anemia, aplastic anemia, thrombocytopenia, leukopenia, leukocytosis, eosinophilia, hepatitis, hepatic necrosis, hepatomegaly, cholestatic jaundice, arthralgia, myopathy, rash, exfoliative, urticarial, and purpuric lesions, erythema multiforme, severe furunculosis of nose, ichthyosis, alopecia, toxic epidermal necrolysis, ecchymoses, chills.
Instructed in new medication Cozaar and in S/E such as dizziness, asthenia, fatigue, headache, insomnia, edema, chest pain, nasal congestion, sinusitis, pharyngitis, sinus disorder, abdominal pain, nausea, diarrhea, dyspepsia, muscle cramps, myalgia, back or leg pain, cough, upper respiratory infection, angioedema, asthenia, fatigue, fever, hypesthesia, chest pain, hypotension, orthostatic hypotension, sinusitis, cataract, diarrhea, dyspepsia, gastritis, urinary tract infection, anemia, hyperkalemia, hypoglycemia, weight gain, back pain, leg or knee pain, muscle weakness, cough, bronchitis, cellulites and others.
Instructed in new medication Prevacid and in S/E such as headache, dizziness, vertigo, malaise, paresthesia, fever, palpitations, flushing, orbital edema, tinnitus, diarrhea, constipation, anorexia, taste perversion, dry mouth, bone and muscle pain, acne, dry skin and transient irritation at I.V. site.